Status:
UNKNOWN
Prediction of Temporomandibular Involvement in Juvenile Idiopathic Arthritis
Lead Sponsor:
Malin Collin
Collaborating Sponsors:
Karolinska Institutet
Conditions:
Juvenile Idiopathic Arthritis
Temporomandibular Arthritis
Eligibility:
All Genders
7-14 years
Brief Summary
Purpose and aims The general aim of this project is to improve the diagnostic methods for disease activity and identify predictive factors (clinical and radiographic factors, pro- and anti-inflammator...
Detailed Description
One-hundred consecutive patients with active JIA, as diagnosed by the Department of Pediatric Rheumatology, Astrid Lindgrens Barnsjukhus, Karolinska University Hospital will be included. Inclusion cr...
Eligibility Criteria
Inclusion
- age between 7 and 14 years
- a diagnosis of JIA according to the International League of Associations for rheumatology (ILAR) The parents of the patients and/or the patients will give their verbal and written informed consent to participate in the study according to the permission from the regional ethical committee 2011/2:1.
Exclusion
- current malignancies
- TMJ surgery or trauma within two years
- recent intra-articular glucocorticoid injection in TMJ (within 1 month)
- other conditions or diseases than JIA that may cause orofacial pain.
Key Trial Info
Start Date :
February 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT02218892
Start Date
February 1 2011
End Date
December 1 2023
Last Update
March 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Folktandvården Stockholmslän AB
Stockholm, Sweden, 14463